At this point, AZ must really regret having gone down the road of working with Oxford to supply a Covid vaccine. They are not even making money off it at the moment. Pfizer on the other hand hit gold with their BioNTech collaboration. They are making 10+ B this year and probably even more in brand value. AZ on the other hand lost billions of brand value. Is there a morale of this story?
The moral of the story is, don't contract to deliver 100 million widgets in a quarter and then actually deliver 30 million widgets. It's pretty simple; remove the vaccine context and there's nothing at all controversial going on here.
Missing production forecasts is one thing, but missing them by this much is unusual and will usually result in trouble for the manufacturer.
Really, I'd say it's more the case that Oxford is regretting working with AZ, rather than a more established vaccine manufacturer.
Comments
At this point, AZ must really regret having gone down the road of working with Oxford to supply a Covid vaccine. They are not even making money off it at the moment. Pfizer on the other hand hit gold with their BioNTech collaboration. They are making 10+ B this year and probably even more in brand value. AZ on the other hand lost billions of brand value. Is there a morale of this story?
I bet a lot of people will hate to hear that but I think the morale of the story is "Don't overpromise and underdeliver".
So far that hasn't hurt Elon Musk a bit...
The moral of the story is, don't contract to deliver 100 million widgets in a quarter and then actually deliver 30 million widgets. It's pretty simple; remove the vaccine context and there's nothing at all controversial going on here.
Missing production forecasts is one thing, but missing them by this much is unusual and will usually result in trouble for the manufacturer.
Really, I'd say it's more the case that Oxford is regretting working with AZ, rather than a more established vaccine manufacturer.
also don't fulfil 1 contract at 100% and another one at 30%..
High risks, high rewards?